We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$87.2B
AUM Growth
-$2.36B
Cap. Flow
-$2.46B
Cap. Flow %
-2.82%
Top 10 Hldgs %
13.2%
Holding
1,014
New
117
Increased
412
Reduced
346
Closed
83

Sector Composition

Rank Sector Weight
1 Energy 16.99%
2 Financials 14.34%
3 Healthcare 13.06%
4 Consumer Discretionary 12.54%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMLP
151
DELISTED
CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE)
CMLP
$153M 0.18%
13,699,148
+60,810
+0.4% +$860K
APLP
152
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
$150M 0.17%
6,686,690
+8,600
+0.1% +$219K
EQR icon
153
Equity Residential
EQR
$25.4B
$150M 0.17%
2,137,575
-87,171
-4% -$6.47M
MEG
154
DELISTED
Media General, Inc
MEG
$149M 0.17%
9,014,848
+696,770
+8% +$11.6M
STZ icon
155
Constellation Brands
STZ
$22.2B
$148M 0.17%
1,279,170
+540,300
+73% +$63.8M
NLSN
156
DELISTED
Nielsen Holdings plc
NLSN
$148M 0.17%
3,305,187
+1,968
+0.1% +$89.2K
EMR icon
157
Emerson Electric
EMR
$82.9B
$146M 0.17%
2,640,434
+33,660
+1% +$1.98M
AOS icon
158
A.O. Smith
AOS
$8.38B
$145M 0.17%
4,027,320
+2,002,180
+99% +$69M
TT icon
159
Trane Technologies
TT
$106B
$144M 0.17%
2,136,390
+1,109,000
+108% +$75.9M
WES
160
DELISTED
Western Gas Partners Lp
WES
$144M 0.17%
2,270,205
-316,221
-12% -$21.5M
MMLP icon
161
Martin Midstream Partners
MMLP
$95.9M
$141M 0.16%
4,549,198
+6,720
+0.1% +$234K
M icon
162
Macy's
M
$6.15B
$140M 0.16%
2,082,232
-1,424,710
-41% -$96.3M
FMX icon
163
Fomento Económico Mexicano
FMX
$43.3B
$139M 0.16%
1,557,056
+20,090
+1% +$1.86M
STJ
164
DELISTED
St Jude Medical
STJ
$137M 0.16%
1,879,440
+24,440
+1% +$1.77M
BNY
165
Bank of New York Mellon
BNY
$108B
$135M 0.15%
3,209,652
+1,559,137
+94% +$66.4M
RSG icon
166
Republic Services
RSG
$66.7B
$135M 0.15%
3,435,475
-21,673
-0.6% -$872K
UHS icon
167
Universal Health Services
UHS
$9.43B
$134M 0.15%
945,984
-59,040
-6% -$7.39M
KSS icon
168
Kohl's
KSS
$2.03B
$134M 0.15%
2,146,300
+293,321
+16% +$20.4M
CLVS
169
DELISTED
Clovis Oncology, Inc.
CLVS
$133M 0.15%
1,517,390
+20,140
+1% +$1.72M
TEVA icon
170
Teva Pharmaceuticals
TEVA
$35.9B
$133M 0.15%
2,252,271
-50,384
-2% -$3.11M
IVZ icon
171
Invesco
IVZ
$13.3B
$133M 0.15%
3,542,572
-1,178,441
-25% -$47.2M
EIX icon
172
Edison International
EIX
$30.7B
$132M 0.15%
2,374,794
+189,747
+9% +$11.4M
GNW icon
173
Genworth Financial
GNW
$3.8B
$132M 0.15%
17,385,911
-4,691,586
-21% -$37.4M
GWRE icon
174
Guidewire Software
GWRE
$11.5B
$131M 0.15%
2,479,709
-2,498
-0.1% -$129K
EOG icon
175
EOG Resources
EOG
$78B
$130M 0.15%
1,484,275
+535,690
+56% +$49.5M

Similar funds

OppenheimerFunds's Q2 2015 Portfolio in Review

As of Q2 2015, OppenheimerFunds held 1,014 positions worth $87.2B, down 2.6% from $89.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

OppenheimerFunds's Q2 2015 filing shows 117 new, 412 increased, 346 reduced and 83 closed positions. Its largest new stake was Trip.com Group: 12,596,284 shares worth $457M. The largest sale was Baidu, an estimated $856M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • OppenheimerFunds's largest Q2 2015 buy was Trip.com Group: 12,596,284 shares worth $457M.
  • OppenheimerFunds added most to Alibaba in Q2 2015, an estimated $561M increase.
  • OppenheimerFunds's biggest Q2 2015 reduction was Baidu, cutting an estimated $856M.
  • OppenheimerFunds fully exited REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS in Q2 2015, selling an estimated $711M.
  • OppenheimerFunds's ten largest holdings make up 13% of its $87.2B portfolio in Q2 2015.
  • OppenheimerFunds opened 117 new positions and closed 83 in Q2 2015.
  • OppenheimerFunds's portfolio value fell 2.6% quarter-over-quarter to $87.2B.

Based on OppenheimerFunds's 13F filing for Q2 2015, filed 6 Aug 2015.